Literature DB >> 24419306

The therapeutic effect of adding emotional awareness training to standard medical treatment for irritable bowel syndrome: a randomized clinical trial.

Alireza Farnam1, Mohammad H Somi, Sara Farhang, Nafiseh Mahdavi, Mohammad Ali Besharat.   

Abstract

OBJECTIVE: This randomized trial evaluated the therapeutic effect of emotional awareness training on the severity and frequency of pain in patients with irritable bowel syndrome (IBS). Patients' level of alexithymia was also measured.
METHOD: The study involved 100 patients diagnosed with IBS according to the Rome-III criteria. Patients' mean age was 34.98 years (standard deviation 10.22 years) and 60% of the patients were female. Seventy eligible patients were assigned randomly to one of two treatment groups. One group received standard symptom-oriented medical treatment only (MT group), while the second group, termed the emotional awareness group (EMT), was educated to increase conscious awareness of eight primary emotions in addition to receiving standard symptom-oriented medical treatment. This study was conducted over 20 months. All patients received 5 weeks of symptom-oriented medical treatment; patients in the EMT group also had two emotion awareness training sessions and recorded their emotions in a daily diary. Sixty patients completed the study.
RESULTS: Patients with IBS scored significantly higher on all aspects of alexithymia compared with healthy controls. The severity of pain decreased significantly in both groups, with a larger percentage of the patients in the EMT group who completed the study having a significant decrease in pain (54% in the EMT group vs. 36% in the MT group); this finding was replicated in an intent-to-treat analysis. The same results were observed for frequency of pain in patients who completed the study (59% in the EMT group vs 43.4% in the MT group), but this finding was not replicated in an intent-to-treat analysis. These patterns were not influenced by level of alexithymia, age, or gender.
CONCLUSION: Adding emotional awareness training to medical treatment resulted in a better therapeutic response in abdominal pain in patients with IBS.

Entities:  

Mesh:

Year:  2014        PMID: 24419306     DOI: 10.1097/01.pra.0000442934.38704.3a

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN: 1527-4160            Impact factor:   1.325


  7 in total

1.  Emotional awareness and expression training improves irritable bowel syndrome: A randomized controlled trial.

Authors:  E R Thakur; H J Holmes; N A Lockhart; J N Carty; M S Ziadni; H K Doherty; J M Lackner; H Schubiner; M A Lumley
Journal:  Neurogastroenterol Motil       Date:  2017-06-22       Impact factor: 3.598

Review 2.  Emotional awareness and other emotional processes: implications for the assessment and treatment of chronic pain.

Authors:  Mark A Lumley; Shoshana Krohner; Liyah M Marshall; Torran C Kitts; Howard Schubiner; Brandon C Yarns
Journal:  Pain Manag       Date:  2021-02-03

3.  Alexithymia in Gastroenterology and Hepatology: A Systematic Review.

Authors:  Danilo Carrozzino; Piero Porcelli
Journal:  Front Psychol       Date:  2018-04-06

4.  Association Between Alexithymia and Functional Gastrointestinal Disorders.

Authors:  Michiko Kano; Yuka Endo; Shin Fukudo
Journal:  Front Psychol       Date:  2018-04-25

Review 5.  Sex-Gender Differences in the Effectiveness of Treatment of Irritable Bowel Syndrome: A Systematic Review.

Authors:  Lente van Kessel; Doreth Teunissen; Toine Lagro-Janssen
Journal:  Int J Gen Med       Date:  2021-03-15

6.  Different Dimensions of Affective Processing in Patients With Irritable Bowel Syndrome: A Multi-Center Cross-Sectional Study.

Authors:  Sabrina Berens; Rainer Schaefert; Johannes C Ehrenthal; David Baumeister; Wolfgang Eich; Jonas Tesarz
Journal:  Front Psychol       Date:  2021-03-29

7.  A Systematic Review of the Effectiveness of Psychological Treatments for IBS in Gastroenterology Settings: Promising but in Need of Further Study.

Authors:  Elyse R Thakur; Jordan Shapiro; Johanna Chan; Mark A Lumley; Jeffrey A Cully; Andrea Bradford; Hashem B El-Serag
Journal:  Dig Dis Sci       Date:  2018-05-10       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.